Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patients (vol 50, 1700050, 2017 )

被引：2
|
作者：
Delaunay, Myriam
Cadranel, Jacques
Lusque, Amelie
Meyer, Nicolas
Gounant, Valerie
Moro-Sibilot, Denis
Michot, Jean-Marie
Raimbourg, Judith
Girard, Nicolas
Guisier, Florian
Planchard, David
Metivier, Anne-Cecile
Tomasini, Pascale
Dansin, Eric
Perol, Maurice
Campana, Marion
Gautschi, Oliver
Fruh, Martin
Fumet, Jean-David
Audigier-Valette, Clarisse
Couraud, Sebastien
Dalle, Stephane
Leccia, Marie-Therese
Jaffro, Marion
Collot, Samia
Prevot, Gregoire
Milia, Julie
Mazieres, Julien
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2017年 / 50卷 / 05期
关键词：
D O I：
10.1183/13993003.50050-2017
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Endocrinopathies induced by immune-checkpoint inhibitors in advanced non-small cell lung cancer
    Rossi, Emanuela
    Sgambato, Assunta
    De Chiara, Giovanni
    Casaluce, Francesca
    Losanno, Tania
    Sacco, Paola Claudia
    Santabarbara, Giuseppe
    Gridelli, Cesare
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 419 - 428
  • [42] Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology
    Manglaviti, Sara
    Brambilla, Marta
    Signorelli, Diego
    Ferrara, Roberto
    Lo Russo, Giuseppe
    Proto, Claudia
    Galli, Giulia
    De Toma, Alessandro
    Occhipinti, Mario
    Viscardi, Giuseppe
    Beninato, Teresa
    Zattarin, Emma
    Bini, Marta
    Lobefaro, Riccardo
    Massa, Giacomo
    Bottiglieri, Achille
    Apollonio, Giulia
    Sottotetti, Elisa
    Di Mauro, Rosa Maria
    Trevisan, Benedetta
    Ganzinelli, Monica
    Fabbri, Alessandra
    de Braud, Filippo G. M.
    Garassino, Marina Chiara
    Prelaj, Arsela
    CLINICAL LUNG CANCER, 2022, 23 (01) : E17 - E28
  • [43] Endocrine-related adverse events associated with immune-checkpoint inhibitors in patients with melanoma
    Kassi, Eva
    Angelousi, Anna
    Asonitis, Nikolaos
    Diamantopoulos, Panagiotis
    Anastasopoulou, Amalia
    Papaxoinis, George
    Kokkinos, Michalis
    Giovanopoulos, Ilias
    Kyriakakis, Georgios
    Petychaki, Fotini
    Savelli, Akrivi
    Benopoulou, Olga
    Gogas, Helen
    CANCER MEDICINE, 2019, 8 (15): : 6585 - 6594
  • [44] BIOMARKER TRENDS AND OUTCOMES IN PATIENTS RECEIVING IMMUNE-CHECKPOINT INHIBITORS
    Vasbinder, Alexi
    Chen, YeeAnn
    Gradone, Allison
    Azam, Tariq
    Perry, Daniel
    Shadid, Husam
    Anderson, Elizabeth
    Catalan, Tonimarie
    Blakely, Pennelope K.
    Nelapudi, Namratha
    Fardous, Mohamad
    Adie, Sarah
    Pogue, Kristen
    Leja, Monika Jacqueline
    Yentz, Sarah
    Schneider, Bryan
    Hayek, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2366 - 2366
  • [45] Immune-checkpoint kinetics for T cells in anti-MDA5 positive interstitial lung disease
    Suzuki, Kunihiro
    Yanagihara, Toyoshi
    Matsumoto, Koichiro
    Chong, Sy Giin
    Ando, Hiroyuki
    Ide, Maako
    Arimura-Omori, Masako
    Hata, Kentaro
    Hamada, Naoki
    RHEUMATOLOGY, 2021, 60 (01) : E14 - E16
  • [46] Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study
    Bersanelli, Melissa
    Lattanzi, Elisabetta
    D'Abbiero, Nunziata
    Buti, Sebastiano
    Leonetti, Alessandro
    Cane, Maria Giulia
    Trapani, Salvatore
    Gravina, Giovanni Luca
    Porzio, Giampiero
    Cannita, Katia
    Di Marino, Pietro
    Grassadonia, Antonino
    Tinari, Nicola
    De Tursi, Michele
    Giaiacopi, Elisa
    Michiara, Maria
    Bordi, Paola
    Perrone, Fabiana
    Caravatta, Luciana
    Trignani, Marianna
    Genovesi, Domenico
    Natoli, Clara
    Ficorella, Corrado
    Tiseo, Marcello
    Cortellini, Alessio
    BIOMEDICAL REPORTS, 2020, 12 (02) : 59 - 67
  • [47] Renal Toxicities in Cancer Patients Receiving Immune-Checkpoint Inhibitors: A Meta-Analysis
    Righini, Matteo
    Mollica, Veronica
    Rizzo, Alessandro
    La Manna, Gaetano
    Massari, Francesco
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (15)
  • [48] Bringing immune-checkpoint inhibitors earlier in the management of non-small cell lung cancer
    Borgeaud, Maxime
    Friedlaender, Alex
    Addeo, Alfredo
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (11) : 2353 - 2358
  • [49] Impact of the Treatment Line on the Risks and Benefits of Immune Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer and Interstitial Lung Disease
    Matsumoto, Kinnosuke
    Shiroyama, Takayuki
    Yamamoto, Yuji
    Miyake, Kotaro
    Takeda, Yoshito
    Kumanogoh, Atsushi
    CHEST, 2022, 162 (01) : E67 - E69
  • [50] Non-inferior clinical outcomes of immune checkpoint inhibitors in non-small cell lung cancer patients with interstitial lung disease
    Tasaka, Yuri
    Honda, Takayuki
    Nishiyama, Naoki
    Tsutsui, Toshiharu
    Saito, Hiroaki
    Watabe, Haruna
    Shimaya, Kazuhiro
    Mochizuki, Akifumi
    Tsuyuki, Shun
    Kawahara, Tatsuo
    Sakakibara, Rie
    Mitsumura, Takahiro
    Okamoto, Tsukasa
    Kobayashi, Masayoshi
    Chiaki, Tomoshige
    Yamashita, Takaaki
    Tsukada, Yoshikazu
    Taki, Reiko
    Jin, Yasuto
    Sakashita, Hiroyuki
    Natsume, Ichirou
    Saitou, Kazuhito
    Miyashita, Yoshihiro
    Miyazaki, Yasunari
    LUNG CANCER, 2021, 155 : 120 - 126
12345